The promyelocytic leukemia gene, PML was originally discovered because of its involvement in acute promyelocytic leukemia (APL) (1–4), and was later shown to encode a homo-multimeric protein with predominant nuclear localization, wide tissue expression, and prevalent tumor suppressive functions, both in hematological and solid malignancies (Figure 1). This evidence concerns the gene PML and leukemia.